Management of Hyperkalaemia

Warning

Assessment/monitoring

  • Plasma potassium
  • ECG monitoring

General management

  • Exclude spurious hyperkalaemia (venous blood gas sample in emergency or seek advice from biochemistry) and check for ECG changes.
  • Identify and treat underlying cause where possible:
    • Potassium supplements, ACE inhibitors, potassium-sparing diuretics and spironolactone should be discontinued.
    • Renal failure - consider referral to renal unit.
    • Hypovolaemia - consider volume expansion with IV sodium chloride 0.9%.
    • Severe acidosis (often associated with renal failure).
    • Hypoaldosteronism e.g. Addison's disease.
  • If hyperkalaemia remains unexplained, more specialised investigation may be appropriate.  Advice may be obtained from your local Biochemistry Department.

 

Drug therapy/treatment options

1.  Confirmed plasma K+5.5 - 6.5 mmol/L

Calcium ResoniumR oral 15g three times daily (in water not fruit juice)

  • Calcium Resonium will not lower potassium acutely.  It is only licensed for hyperkalaemia due to anuria or oliguria.
  • Resonium A can be used if there is a risk of hypercalcaemia.
  • Monitor plasma K+ < 5.5mmol/L

2.  Confirmed plasma K+ > 6.5 mmol/L and/or ECG changes

(Although treatment should not be dleayed, result should be confirmed):

10 ml calcium gluconate 10% - slow IV injection over 5 - 10 minutes given by a doctor (to antagonise the effect of potassium on the heart).

8 units soluble insulin (ActrapidR) in 100ml IV glucose 20% vial over 30 minutes (to move potassium into the cells).  This may be repeated once and/or followed by an infusion of the same mixture 5 -10 ml/hour.

and/or

5-10mg nebulised salbutamol

Notes

  • Calcium gluconate may be repeated after 5 minutes if ECG changes persist.
  • Check plasma K+ and glucose one hour after glucose/insulin infusion.
  • Glucose/insulin infusions should be repeated until plasma K+ < 6.5 mmol/L.
  • Hyperosmolal glucose infusions should not be used in diabetic ketoacidosis.

Editorial Information

Last reviewed: 31/05/2024

Next review date: 30/05/2025

Approved By: GGC Medicines Adult Therapeutics Handbook

Reviewer name(s): Kim Kilmurray.

Document Id: 24

Internal URL: http://www.staffnet.ggc.scot.nhs.uk/Acute/Emergency%20Care%20Med%20Specialities/Emergency%20Medicine%20and%20Emergency%20Services/SGHED/Documents/Local%20Guidelines/Gen%20Med/Hyperkalaemia.pdf